Abstract: High mortality rates have been reported for methadone in both adults and children. We aimed to determine the pattern of toxicity, possible underlying diseases and treatment challenges in patients referred to our centre with early diagnosis of methadone toxicity and who later died. Medical files of all methadone-poisoned patients who had been admitted to a referral centre of toxicology between March 2011 and March 2016, died during the hospital stay and sent for autopsy to Legal Medicine Organization were retrospectively evaluated. In a total of 94 patients, autopsy findings and laboratory evaluations showed that cause of death was pure methadone toxicity in 57 (60.6%). Other causes of death were ischaemic heart disease in ten, co-ingestions (toxicities including methadone) in eight, brain haemorrhage, multi-organ failure and pneumosepsis (each in four), meningitis/encephalitis in three and head trauma and other toxicities (other than methadone but including an opioid, each in two) patients. Time of cardiopulmonary arrest was significantly different between those with pure methadone toxicity and those who died due to other causes (p = 0.01). Patients who had died due to co-ingestions and other toxicities were younger (p = 0.029) and took more bolus doses of naloxone (p = 0.042). In methadone users, especially in older ages and those with trivial response to naloxone administration, loss of consciousness should not be strictly attributed to methadone toxicity. In such patients, thorough evaluation for other possible causes of loss of consciousness is mandatory.
Drug overdose deaths nearly tripled during 1999-2014 in the USA and almost 61% involved an opioid [1] . Methadone is an opioid agonist generally used in the methadone maintenance therapy (MMT) programmes with encouraging results in the field of drug abstinence [2] . On the other hand, it has been reported to be one of the most dangerous opioids with significant undesirable effects on the central respiratory and nervous systems [3] . High mortality rates have been reported with this drug in both adults and children [4] .
Importance
With a significant long half-life of 25-52 hr [2, 3] , methadone can cause delayed clinical manifestations including respiratory depression, apnoea and even death. Interestingly, when the patient is apparently improving during hospitalization, he/she may suddenly deteriorate, and the situation can lead to death in extreme cases [4] . In some cases, the patient remains completely well until sudden death occurs with questionable relationship to the poisoning. The most important questions a clinical toxicologist encounters are as follows: For how long should a methadone-poisoned patient be considered critical and monitored? What is the main cause of rapid deterioration of a previously well methadone-intoxicated patient? Is insufficient antidote the cause of re-development of critical condition in a patient with primary acceptable treatment results? And finally, the most important question is what is the cause of death in an assumed methadone-poisoned patient?
In fact, some of the patients who refer to tertiary poisoning centres with the primary diagnosis of methadone toxicity are actually methadone users with some undiagnosed background condition which is fatal, per se. A dependent patient may ingest methadone on a regular basis. A non-dependent patient may ingest methadone to alleviate an already existing condition including a headache that can be due to any reason including head trauma and brain haemorrhage. In such conditions, the main cause of morbidity should not be neglected by the inaccurate or imprecise history given by the patient or his/ her next of kin. Such patients are not always intoxicated and their admission to toxicology wards may postpone their adequate investigation to conclude on an accurate diagnostic and proper treatment. Therefore, when evaluating a methadoneintoxicated patient, emergency physicians should be alert to admit him/her to most appropriate unit/ward and help the patient receive proper treatment by the appropriate managing service.
Aims of this Investigation
The main aim of the current study was to determine the pattern of toxicity, possible underlying diseases and treatment challenges in patients who died after referral to a tertiary poisoning centre with primary diagnosis of methadone toxicity. We aimed to determine which factors could probably make the ED physicians suspect other causes of morbidity in a patient with a positive history of methadone ingestion.
Materials and Methods
Study design and setting, selection of participants. In a retrospective single-centre study, files of all patients who had been referred and admitted to our toxicology complex with primary diagnosis of methadone toxicity between March 2011 and March 2016 (5 years), died during the hospital stay and sent for autopsy to Legal Medicine Organization (LMO) were evaluated. Loghman-Hakim Hospital Poison Center (LHHPC) is the main referral hospital for poisoned patients in Tehran (the capital city with 12.5 million permanent and 6.5 million temporary residents). Between 24,000 and 27,000 intoxicated patients refer to this centre annually, of whom approximately 10,000-12,000 are hospitalized. Opioids including methadone are one of the main causes of intoxication in this centre which is supposed to be the biggest inpatient clinical toxicology centre in the world [5] [6] [7] [8] .
Those who had not been referred to LMO for further evaluations and those for whom a cause of death other than methadone toxicity had been determined during hospital stay were excluded. A self-made questionnaire containing demographic characteristics of the patients, history of addiction or abuse, amount and formulation (syrup versus tablet) of the ingested methadone (if known), time elapsed between methadone ingestion and hospital presentation, on admission clinical manifestations and laboratory tests, development of clinical manifestations during hospitalization, treatment performed including dose and duration of antidote therapy and intubation, response to the administered antidote, duration of hospital stay, complications, autopsy findings and the final cause of death determined by LMO was filled for every single patient.
Blood gas (BG) analyses were interpreted based on arterial or venous route of the samples [9] . Cases with cardiac arrest before hospital admission were excluded from BG analysis. At hospital, diagnosis of methadone toxicity was made based on the positive history of methadone ingestion and confirmed by a positive urine methadone screening test, development of opioid syndrome and response to naloxone (increased AVPU scale [alert, responds to voice, responds to pain, unresponsive] after its administration). In LMO, diagnosis of methadone toxicity was made based on the patients' clinical charts and thin-layer chromatography test for methadone only if no other potentially fatal finding, including qualitative laboratory examination for other toxins, was detected during autopsy.
Methods and measurements. Cause of death was determined by a forensic medicine specialist using the laboratory tests and summary of clinical data and autopsy findings in LMO. In all cases, the final diagnosis made by LMO and patients' hospital files was re-evaluated by three forensic medicine specialists, two of whom were also clinical toxicologists to reach a consensus on the main cause of death. In case the researchers did not reach a consensus, the senior researcher (corresponding author) discussed with the other two experts. If he was unable to reach a consensus with them, the final decision was made by at least two votes of three.
Outcome. The primary outcome was main cause of death (methadone toxicity or not) according to the available LMO data. Secondary outcome was time of cardiac or respiratory arrest after methadone ingestion or after naloxone discontinuation. Withdrawal or poisoning manifestations after naloxone administration were also considered as secondary outcome.
Dramatic response to naloxone was considered as 'complete recovery', for example complete awakening and obedience after intravenous (IV) administration of naloxone. If, however, the level of consciousness increased inconsequentially after naloxone administration with remaining loss of consciousness, the response was considered 'relative' or 'incomplete'.
For further analysis, final consensus on cause of death was categorized into toxicity-related and non-toxicity-related deaths. Those who died due to toxicity were divided into three groups: those who died due to pure methadone toxicity (group 1), those who died due to coingestions (ingestion of toxicants including methadone; group 2) and those who died due to other toxicities (opioids other than methadone AE some other medication/illicit drugs; group 3). For clinical evaluations, all toxicity-related deaths were also divided into primary (deaths directly due to opioid-induced respiratory depression) versus secondary (deaths due to infection, hypoxic brain damage, etc. after initial opioid overdose); fig. 1 .
Analysis.
For the description of quantitative variables with normal and non-normal distribution, mean (AES.D.) and median (interquartile range) were used, respectively. For qualitative variables, per cent of frequency was used. For comparing continuous variables between two groups, t-test and Fisher's exact test were used, respectively. The Mann-Whitney U-test was used to compare differences between two independent groups when the dependent variable was continuous but not normally distributed. For the assessment of association between categorical variables, chi-square was used. Odds ratio (OR) and 95% confidence interval (CI) were used for expressing the severity of this association. Pearson correlation coefficient for assessing the severity of association between continuous variables was used. "Enter" logistic model was performed for determining independent variables predicting death in these patients. A p value less than 0.05 was considered statistically significant. Statistical package for social sciences (SPSS) version 17.0 (SPSS Inc., Chicago, Ill, USA) was used for the analysis. The local institutional ethics committee approved the study.
Results

Characteristics of the study individuals.
Of a total of 6271 methadone-overdosed patients who had been admitted to our centre during the study period (763, 925, 1281, 1579 and 1723 patients between March 2011 and March 2016, respectively), 121 (1.93%) had died. The contribution of methadone in toxicity-related death rate increased from 13% in 2011 to 27%, 19%, 23% and 19% in 2012, 2013, 2014 and 2015 (until March 2016), respectively. Twenty-seven had not been sent to LMO for forensic examination and their death certificate had been issued at the hospital and they were therefore excluded. Finally, 94 patients were included and evaluated ( fig. 2 ).
Main results.
Eighty patients (85.1%) were males. Their mean age was 44 AE 18 years (range; 2 months to 85 years). Twenty-two were referred completely conscious while 23 (24.5%) and five (5.3%) were referred with respiratory and cardiac arrest, respectively. Seven patients were intubated before presentation to our centre by EMS personnel or medical staff in the primary centre which had referred them. Naloxone was administered to 23 (24.5%) patients before presentation. Median time elapsed between ingestion and hospital presentation was 10 [5, 24] hr. The basic characteristics of the patients are shown in table 1.
After admission to the toxicological emergency department (ED), 36 patients (38.3%) received median [IQR] naloxone of 0.4 mg [0.4, 0.95] (range, 0.04, 5.6 mg) while three who did not need naloxone before presentation or after ED admission, developed respiratory depression and needed naloxone after admission to the ward. Thirty-one patients received naloxone infusion during hospitalization with an average dose of 0.4 [0.25, 0.6] mg/hr (range, 0.1, 2 mg/hr) for 11 [8, 17] hr (range, 2, 114 hr). Four (4.3%) and 26 (27.7%) showed complete and relative/incomplete response to naloxone administration while eight (8.4%) had not responded to antidote therapy at all. In 55 cases (58.5%), the response to naloxone had not been determined in the charts. Autopsy findings and laboratory evaluations showed that cause of death was pure methadone intoxication, ischaemic heart disease, co-ingestions (toxicities including methadone), brain haemorrhage, multi-organ failure, pneumosepsis, meningitis/encephalitis, other toxicities (other than methadone but including an opioid) and head trauma in 57, 10, eight, four, four, four, three, two and two patients, respectively ( fig. 2 ). In fact, only 67 deaths (71%) were toxicity-related and in the remaining 27 patients, cause of death was something irrelevant to toxicity. table 2 compares the 67 toxicity-related and 27 non-toxicity-related deaths as well as primary and secondary deaths. Logistic regressions failed to identify any clinical parameter that could significantly predict death in the abovementioned three groups; table 2. Table 3 shows the autopsy findings and test results for drugs/medications determined by LMO.
As shown in table 2, age (p = 0.029) and bolus administration of naloxone (p = 0.042) were significantly different between toxicity-related deaths and patients who died due to other causes, while arrest time was significantly different between group 1 and the others (p = 0.01). Blood gas analyses showed no statistical differences between group 1 and the others. However, comparing BG analysis in primary and secondary deaths revealed that respiratory acidosis was more common in primary deaths (all of which were due to methadone; p = 0. 
Discussion
Methadone use/abuse has significantly increased during recent years resulting in higher sensitivity of medical staff to methadone toxicity [10] [11] [12] [13] [14] [15] [16] . In fact, considering miotic pupils in opioid-dependent patients arriving in comatose state, medical staff may falsely assume that the patient is methadoneintoxicated and treat him/her as a poisoned patient while the main background disease making the patient refer to the healthcare facility may be completely irrelevant to methadone intoxication. As noticed in our study, mortality rate may be increased during periods off MMT programmes [17] . In accordance with the study by Gao et al., mortality may be more prominent in older patients compared with younger ones [18] . Considering the relative/incomplete response to naloxone in dependent patients whose loss of consciousness may be due to reasons other than opioid toxicity, it may be even more misleading when there is no significant difference in their naloxone dose compared with those who dramatically respond to naloxone. These patients may experience withdrawal syndrome and become agitated after naloxone administration making them move more resulting in the conclusion of response to naloxone. This phenomenon is shown in table 2 comparing AVPU scale in response to naloxone in toxicityrelated versus non-toxicity-related deaths and pure methadone versus all other causes. In some cases, delay in determination of the background disease or administration of the antidote (naloxone) may be fatal [19] . Precipitated withdrawal syndrome in a dependent patient may result in death [20, 21] . Ten patients (10.6%) had died due to ischaemic heart disease. Possibly, naloxone was contra-indicated in them [22] . On the other hand, brain trauma and haemorrhage discovered during the autopsy as well as sepsis and multi-organ failure determined as the causes of death needed specific treatments with which the patient might have had a higher chance of survival. This is why the first diagnosis of methadone toxicity had misled the medical staff from the main illness. Relative response to naloxone (lack of dramatic/complete response to it) may again show the fact that many patients were actually methadone-dependent and not methadone-poisoned.
As shown in table 2, the patients who died due to non-toxicity-related deaths were almost one decade older and needed less doses of naloxone to reverse their opioid syndrome signs/ symptoms. Therefore, in cases with possible methadone poisoning who do not dramatically respond to naloxone administration, further evaluations should be performed to determine the cause of loss of consciousness in appropriate time and patients' manifestations should not be strictly attributed to methadone intoxication. Urine screening tests should not be relied on for diagnosis of methadone intoxication and determined to be the cause of patients' manifestations, either, as they are also positive in dependent patients with other causes of loss of consciousness. Although not studied here, even serum concentration of methadone and its metabolite may fail to distinguish between regular basis and overdose mainly due to individual tolerance in each patient [23] [24] [25] .
Relatively long hospital stay may interfere with the postmortem laboratory test evaluations. Forensic laboratory tests had not been performed in 63 patients in LMO mainly because of the long hospital stay before death which makes final conclusion difficult.
In our series, some patients were alert and awake on presentation but developed hypoxic complications due to opioid toxicity (mainly opioid-induced apnoea) during the hospital stay. All of these cases needed ICU admission but lack of ICU beds in our setting makes the management inefficient. Comparison of primary versus secondary deaths shows significantly higher level of consciousness on presentation and after naloxone treatment, delayed intubation, duration of naloxone infusion after the first bolus dose of naloxone and conservative treatments, higher risk of hypoventilation and hypoxia and less background complications (including rhabdomyolysis and abnormal liver function tests) in those with primary deaths. The possible cause of insufficient naloxone dose or its discontinuation is mainly initial wrong doses of naloxone (wrong measurement of the first bolus doses of naloxone) and subsequent wrong high doses of naloxone infusion that had resulted in withdrawal mandating discontinuation of the naloxone infusion and subsequent respiratory arrest due to it.
Although not evaluated, it seems there is no difference in myocardial and coronary indices between methadone-na€ ıve and methadone-dependent patients and the most common cause of death is respiratory depression in all groups [26] . Pulmonary oedema reported in autopsy findings is compatible with opioid toxicity and is reported several times in previous methadone-related death studies [27, 28] . However, iatrogenic withdrawal syndrome caused by naloxone administration would still be a risk factor for mortality [22] . A 17-hr (75% interquartile range) gap between naloxone discontinuation and respiratory arrest or distress (table 4) mandating endotracheal intubation revealed that the routine practice of 6-to 8-hr naloxone-free time may not be enough for all patients and a longer observation period after naloxone discontinuation is needed. This has already been declared in methadone toxicity in children who are the most common victims of fatal accidental pharmaceutical poisonings [29, 30] . Position statements do not routinely recommend gastric lavage in poisoned patients and limit it to special situations, although this is not studied in methadone toxicity [31] . There are strong clinical data suggesting the role of opioids and particularly methadone in delayed gastrointestinal emptying at either therapeutic dose or overdose [32, 33] . In the study of Verma et al., methadone-dependent patients had a significant gastrointestinal delay compared to opioid-na€ ıve patients mandating repeated colonoscopy due to the presence of solid stool in them. They found a significant correlation between daily dose of methadone and gastrointestinal dysmotility [34] .
Adams et al. showed that a considerable number of poisoned patients (including opioids) had gastric emptying halftimes above 300 min. This delay may postpone the drug entry into the small intestine and decrease further drug absorption in the intestine. Long half-life, concomitant gastrointestinal dysmotility and current results may explain why the observation period following methadone toxicity should be re-evaluated to improve the clinical course and patient management [31] .
Some patients experienced respiratory distress on naloxone infusion which could be due to pulmonary complications of methadone toxicity or naloxone itself.
Limitations
Lack of determination of quantitative methadone concentration is a major limitation of the current study. The retrospective nature of the study and lack of documentation of some variables were other major limitations. We did not study the electrocardiogram to see possible changes in the QT interval that might influence the reported outcome, either [10, 11] .
Conclusion
Risks associated with methadone ingestion are often underestimated by clinicians prescribing the drug. Methadone may be prescribed without taking into account the patient's tolerance to opiates, and a large number of individuals enrolled in MMT programmes are given take-home doses increasing the risk of abuse and toxicity.
Methadone-intoxicated patients generally need follow-up evaluations for longer hours after ingestion because of the long drug half-life and gastrointestinal dysmotility. Unfortunately, lack of intensive care beds for intoxicated patients may result in patient admission in crowded wards with lack of close intensive monitoring increasing the risk of mortality and morbidity in these patients. On the other hand, loss of consciousness should not be strictly attributed to methadone, especially in dependent patients who relatively/incompletely respond to naloxone and complete evaluation of the dependent patients who refer with loss of consciousness and do not dramatically respond to naloxone is mandatory. Naloxone may produce opioid withdrawal syndrome that can lead to aspiration pneumonia or progression of the underlying diseases and result in mortality and morbidity. Close monitoring and ruling out of other probable differential diagnosis are recommended when observing incomplete/no response to naloxone in methadone-poisoned patients.
